IRAK1 and Autoimmunity: These observations, together with the efficacy of an IRAK4 inhibitor in reducing autoimmunity imply that TLR7-MyD88-IRAK4-IRAK1 signaling is up-regulated in MRL/lpr and NZB/W mice, but the mechanism(s) causing hyperactivation in these mouse strains is (are) unclear.